New York man sues MRI firm over missed stroke risk

A New York man has filed a lawsuit against Prenuvo, claiming its $2,500 whole-body MRI scan failed to detect a critical artery narrowing that led to his massive stroke months later. Sean Clifford argues that early intervention could have prevented his severe disabilities. The case highlights ongoing debates about the reliability of elective full-body scans.

Sean Clifford underwent a whole-body MRI scan at Prenuvo on July 15, 2023, costing $2,500. The imaging revealed a 60 percent narrowing and irregularity in the proximal right middle cerebral artery, a key vessel often linked to strokes. However, Prenuvo's report stated that his brain appeared normal, with no adverse findings flagged.

Nearly eight months later, on March 7, 2024, Clifford suffered a devastating stroke when the artery became fully blocked. The incident left him with paralysis in his left hand and leg, weakness on his left side, permanent vision loss including double vision, and challenges including anxiety, depression, mood swings, cognitive issues, speech difficulties, and struggles with daily activities.

In September 2024, Clifford sued Prenuvo in New York State Supreme Court, asserting that awareness of the issue could have prompted stenting or other preventive measures. Prenuvo, based in California and backed by figures like Kim Kardashian, Cindy Crawford, and Anne Wojcicki, attempted to enforce arbitration and apply California's damage caps, but a judge rejected both motions in December. The court also refused to protect the reviewing radiologist, William A. Weiner, whose medical license was suspended over falsified MRI reports in an insurance fraud case.

Clifford's lawyer, Neal Bhushan, welcomed the ruling: “I am pleased that the court sided with us. This ruling reaffirms the strength and merits of our medical malpractice and negligence claims, and we look forward to continuing to litigate this matter in New York County Supreme Court.” Prenuvo responded: “We take any allegation seriously and are committed to addressing it through the appropriate legal process. Our focus remains on delivering safe, high quality, proactive care to the patients who place their trust in us every day.”

The lawsuit underscores broader concerns about elective whole-body MRIs, which are not insurance-covered and lack endorsement from bodies like the American College of Radiology. Critics argue these scans often yield insignificant findings, prompting unnecessary tests and exacerbating healthcare inequities, while potentially overlooking serious issues in non-targeted reviews.

Relaterede artikler

Illustration of heart risk tools failing to detect hidden arterial plaque in a patient, highlighting study findings on screening limitations.
Billede genereret af AI

Study: Heart-attack risk tools fail to flag nearly half of future patients

Rapporteret af AI Billede genereret af AI Faktatjekket

A Mount Sinai–led study finds that commonly used heart-attack risk calculators and symptom-based screening fail to identify nearly half of people who will soon experience a first heart attack. The brief report, published November 21 in JACC: Advances, underscores limitations in current prevention strategies and argues for earlier imaging to detect silent plaque.

Researchers at the University of Michigan have developed an AI system called Prima that interprets brain MRI scans in seconds, identifying neurological conditions with up to 97.5% accuracy. The tool also flags urgent cases like strokes and brain hemorrhages, potentially speeding up medical responses. Findings from the study appear in Nature Biomedical Engineering.

Rapporteret af AI

A citizen complaint has raised alarms about failures in key diagnostic equipment at Neiva's Hospital Universitario Hernando Moncaleano Perdomo, impacting diagnostics for critical patients and those with cancer. The institution confirms breakdowns in tomographs and a magnetic resonance imager, with a mammograph also reported damaged. A contingency plan has been activated to sustain urgent care.

New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.

Rapporteret af AI

Epia Neuro, a newly launched startup in San Francisco, is developing a brain-computer interface to help stroke patients regain hand movement. The system combines a brain implant with a motorized glove. Stroke remains a leading cause of long-term disability, affecting hand and arm function in about two-thirds of survivors.

Chinese biotech firm SciNeuro Pharmaceuticals has partnered with Swiss pharmaceutical giant Novartis in a deal worth nearly $1.7 billion to develop treatments for Alzheimer's disease, which affects some 55 million people worldwide. The agreement grants Novartis exclusive worldwide rights to develop and commercialise SciNeuro's antibody candidates for the progressive brain disease. SciNeuro's novel amyloid beta-targeted antibody programme leverages proprietary blood-brain barrier shuttle technology to help more of the drug cross into the brain where Alzheimer's damage occurs.

Rapporteret af AI Faktatjekket

Researchers have developed a deep learning model that estimates chronic stress burden by measuring adrenal gland volume on standard CT scans, introducing what they describe as the first imaging-based biomarker for chronic stress. The metric, called the Adrenal Volume Index, is linked to cortisol exposure, perceived stress, overall physiological stress load and long-term cardiovascular risk, according to findings to be presented at the Radiological Society of North America's annual meeting.

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis